Promoting Children's Participation in Conventional X-ray Examinations
Launched by LUND UNIVERSITY · Mar 18, 2024
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how children participate during conventional X-ray examinations, which are common imaging tests used to see inside the body. The study aims to understand how many X-ray images need to be taken again, why they might need to be redone, how long the exams take, and how children feel during the process. Researchers will also check the children's heart rates to see if there are any changes that could indicate how they are experiencing the procedure.
To take part in this study, children aged 4 to 12 years who are scheduled for a standard X-ray exam, along with their parents and the assigned radiographers, are eligible. Participants will answer questionnaires about the child's experience during the exam, and their heart rates will be monitored. This study is currently recruiting participants, and it’s important to note that children with cognitive or language difficulties, as well as their parents, will not be included. This research could help improve the way X-ray examinations are performed for children in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children ages 4-12 yrs who undergo standard x-ray examinations
- • parents to the child
- • assigned radiographers
- Exclusion Criteria:
- • Children and parents who have cognitive and/or language difficulties
About Lund University
Lund University, a prestigious research institution in Sweden, is renowned for its commitment to advancing scientific knowledge and innovation in healthcare. With a strong emphasis on interdisciplinary collaboration, the university conducts cutting-edge clinical trials aimed at addressing critical health challenges. Leveraging its state-of-the-art facilities and a diverse network of expert researchers, Lund University strives to translate research findings into effective therapeutic solutions, ultimately improving patient outcomes and enhancing public health. Through its dedication to ethical research practices and patient safety, Lund University plays a pivotal role in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lund, Skane, Sweden
Patients applied
Trial Officials
Pether Jildenstål, Assoc. Prof.
Study Director
Lund University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported